|
|
Blood, 1 May 2005, Vol. 105, No. 9, pp. 3397-3404.
Prepublished online as a Blood First Edition Paper on January 18, 2005; DOI 10.1182/blood-2004-07-2618.
Previous Article | Next Article 
Submitted July 13, 2004
Accepted December 27, 2004
Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes
Pam Massullo, Lawrence J Druhan, Bruce A Bunnell, Melissa G Hunter, John M Robinson, Clay B Marsh, and Belinda R Avalos*
The Bone Marrow Transplant Program, The Ohio State University, Columbus, OH, USA
The Division of Hematology/Oncology, The Ohio State University, Columbus, OH, USA
The Molecular, Cellular, and Developmental Biology Program, The Ohio State University, Columbus, OH, USA
Department of Pharmacology, Center for Gene Therapy, Tulane University Health Science Center, New Orleans, LA, USA
Division of Pulmonary and Critical Care Medicine, The Ohio State University, Columbus, OH, USA
Department of Physiology, The Ohio State University, Columbus, OH, USA
* Corresponding author; email: avalos-1{at}medctr.osu.edu.
Mutations in the ELA2 gene encoding neutrophil elastase (NE) are present in the majority of patients with severe congenital neutropenia (SCN). However, the mechanisms by which these mutations cause neutropenia remain unknown. To investigate the effects of expression of mutant NE on granulopoiesis, we used the HL-60 promyelocytic cell line retrovirally transduced with the G185R NE mutant that is associated with a severe SCN phenotype. We show that the mutant enzyme accelerates apoptosis of differentiating but not proliferating cells. Using metabolic labeling, confocal immunofluorescence microscopy, and immunoblot analysis of subcellular fractions, we also demonstrate that the G185R mutant is abnormally processed and localizes predominantly to the nuclear and plasma membranes instead of the cytoplasmic compartment observed with the wild-type (WT) enzyme. Expression of the G185R mutant appeared to alter the subcellular distribution and expression of adaptor protein 3 (AP3), which traffics proteins from the trans-Golgi to the endosome. These observations provide further insights into potential mechanisms by which NE mutations cause neutropenia and suggest that abnormal protein trafficking and accelerated apoptosis of differentiating myeloid cells contribute to the severe SCN phenotype resulting from the G185R mutation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Neutrophil elastase unleashed
- Marshall Horwitz
Blood 2005 105: 3392-3393.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
P. Rujkijyanont, K.-i. Watanabe, C. Ambekar, H. Wang, A. Schimmer, J. Beyene, and Y. Dror
SBDS-deficient cells undergo accelerated apoptosis through the Fas-pathway
Haematologica,
March 1, 2008;
93(3):
363 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Grenda, M. Murakami, J. Ghatak, J. Xia, L. A. Boxer, D. Dale, M. C. Dinauer, and D. C. Link
Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis
Blood,
December 15, 2007;
110(13):
4179 - 4187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Donini, S. Fontana, G. Savoldi, W. Vermi, L. Tassone, F. Gentili, E. Zenaro, D. Ferrari, L. D. Notarangelo, F. Porta, et al.
G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms
Blood,
June 1, 2007;
109(11):
4716 - 4723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. U. Niemann, M. Abrink, G. Pejler, R. L. Fischer, E. I. Christensen, S. D. Knight, and N. Borregaard
Neutrophil elastase depends on serglycin proteoglycan for localization in granules
Blood,
May 15, 2007;
109(10):
4478 - 4486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Horwitz, Z. Duan, B. Korkmaz, H.-H. Lee, M. E. Mealiffe, and S. J. Salipante
Neutrophil elastase in cyclic and severe congenital neutropenia
Blood,
March 1, 2007;
109(5):
1817 - 1824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kollner, B. Sodeik, S. Schreek, H. Heyn, N. von Neuhoff, M. Germeshausen, C. Zeidler, M. Kruger, B. Schlegelberger, K. Welte, et al.
Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response
Blood,
July 15, 2006;
108(2):
493 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Enders, B. Zieger, K. Schwarz, A. Yoshimi, C. Speckmann, E.-M. Knoepfle, U. Kontny, C. Muller, A. Nurden, J. Rohr, et al.
Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II
Blood,
July 1, 2006;
108(1):
81 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zhuang, Y. Qiu, S. C. Kogan, and F. Dong
Increased CCAAT Enhancer-binding Protein {epsilon} (C/EBP{epsilon}) Expression and Premature Apoptosis in Myeloid Cells Expressing Gfi-1 N382S Mutant Associated with Severe Congenital Neutropenia
J. Biol. Chem.,
April 21, 2006;
281(16):
10745 - 10751.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|